Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Dentate gyrus volume deficit in schizophrenia.

Nakahara S, Turner JA, Calhoun VD, Lim KO, Mueller B, Bustillo JR, O'Leary DS, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Macciardi F, Matsumoto M, Potkin SG, van Erp TGM.

Psychol Med. 2019 Jun 3:1-11. doi: 10.1017/S0033291719001144. [Epub ahead of print]

PMID:
31155012
2.

A working memory related mechanism of auditory hallucinations.

Gaudiot C, Du X, Summerfelt A, Hare SM, Bustillo JR, Rowland LM, Hong LE.

J Abnorm Psychol. 2019 Jul;128(5):423-430. doi: 10.1037/abn0000432. Epub 2019 May 6.

PMID:
31058523
3.

A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.

Hanlon FM, Yeo RA, Shaff NA, Wertz CJ, Dodd AB, Bustillo JR, Stromberg SF, Lin DS, Abrams S, Liu J, Mayer AR.

Schizophr Res. 2019 Jun;208:344-352. doi: 10.1016/j.schres.2019.01.024. Epub 2019 Jan 31.

PMID:
30711315
4.

Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.

Bustillo JR, Jones T, Qualls C, Chavez L, Lin D, Lenroot RK, Gasparovic C.

J Affect Disord. 2019 Mar 1;246:745-753. doi: 10.1016/j.jad.2018.12.064. Epub 2018 Dec 21.

PMID:
30623820
5.

Spatial dynamics within and between brain functional domains: A hierarchical approach to study time-varying brain function.

Iraji A, Fu Z, Damaraju E, DeRamus TP, Lewis N, Bustillo JR, Lenroot RK, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD.

Hum Brain Mapp. 2019 Apr 15;40(6):1969-1986. doi: 10.1002/hbm.24505. Epub 2018 Dec 26.

PMID:
30588687
6.

A Rare Culprit of Spontaneous Abortion, Latent Tuberculosis Complicated by Disseminated Peritoneal TB.

Sossou C, Pal C, Bustillo JR.

Case Rep Infect Dis. 2018 Oct 28;2018:2318539. doi: 10.1155/2018/2318539. eCollection 2018.

7.

The Meaning of Glutamate and the Quest for Biomarkers in the Transition to Psychosis.

Bustillo JR, Gaudiot CE, Lenroot RK.

JAMA Psychiatry. 2019 Feb 1;76(2):115-116. doi: 10.1001/jamapsychiatry.2018.3251. No abstract available.

PMID:
30427988
8.

A framework for linking resting-state chronnectome/genome features in schizophrenia: A pilot study.

Rashid B, Chen J, Rashid I, Damaraju E, Liu J, Miller R, Agcaoglu O, van Erp TGM, Lim KO, Turner JA, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Bustillo JR, Pearlson GD, Calhoun VD.

Neuroimage. 2019 Jan 1;184:843-854. doi: 10.1016/j.neuroimage.2018.10.004. Epub 2018 Oct 6.

PMID:
30300752
9.

Reading the (functional) writing on the (structural) wall: Multimodal fusion of brain structure and function via a deep neural network based translation approach reveals novel impairments in schizophrenia.

Plis SM, Amin MF, Chekroud A, Hjelm D, Damaraju E, Lee HJ, Bustillo JR, Cho K, Pearlson GD, Calhoun VD.

Neuroimage. 2018 Nov 1;181:734-747. doi: 10.1016/j.neuroimage.2018.07.047. Epub 2018 Jul 25.

10.

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2018 Nov 1;84(9):644-654. doi: 10.1016/j.biopsych.2018.04.023. Epub 2018 May 14.

11.

A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.

Preda A, Nguyen DD, Bustillo JR, Belger A, O'Leary DS, McEwen S, Ling S, Faziola L, Mathalon DH, Ford JM, Potkin SG; FBIRN, van Erp TGM.

Schizophr Res. 2018 Nov;201:113-119. doi: 10.1016/j.schres.2018.06.014. Epub 2018 Jun 20.

PMID:
29935887
12.

Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.

Nakahara S, Medland S, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Vaidya JG, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, van Erp TGM.

Schizophr Res. 2018 Nov;201:393-399. doi: 10.1016/j.schres.2018.05.041. Epub 2018 Jun 12.

PMID:
29907492
13.

Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia.

Lin D, Chen J, Perrone-Bizzozero N, Bustillo JR, Du Y, Calhoun VD, Liu J.

Genome Med. 2018 Feb 26;10(1):13. doi: 10.1186/s13073-018-0519-4.

14.

Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1.

Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, Potkin SG, van Erp TGM, Macciardi F, Ehrlich S, Ho BC, Sponheim SR, Wang L, Stephen JM, Mayer AR, Hanlon FM, Jung RE, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, Tamminga CA, Andreassen OA, Agartz I, Westlye LT, Sui J, Du Y, Turner JA, Liu J.

Schizophr Bull. 2019 Jan 1;45(1):222-232. doi: 10.1093/schbul/sby010.

PMID:
29474680
15.

Functional connectivity during affective mentalizing in criminal offenders with psychotic disorders: Associations with clinical symptoms.

Harenski CL, Calhoun VD, Bustillo JR, Haas BW, Decety J, Harenski KA, Caldwell MF, Van Rybroek GJ, Koenigs M, Thornton DM, Kiehl KA.

Psychiatry Res Neuroimaging. 2018 Jan 30;271:91-99. doi: 10.1016/j.pscychresns.2017.11.003. Epub 2017 Nov 6.

16.

Multimodal Neuroimaging in Schizophrenia: Description and Dissemination.

Aine CJ, Bockholt HJ, Bustillo JR, Cañive JM, Caprihan A, Gasparovic C, Hanlon FM, Houck JM, Jung RE, Lauriello J, Liu J, Mayer AR, Perrone-Bizzozero NI, Posse S, Stephen JM, Turner JA, Clark VP, Calhoun VD.

Neuroinformatics. 2017 Oct;15(4):343-364. doi: 10.1007/s12021-017-9338-9.

17.

Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia.

Bustillo JR, Patel V, Jones T, Jung R, Payaknait N, Qualls C, Canive JM, Liu J, Perrone-Bizzozero NI, Calhoun VD, Turner JA, Gasparovic C.

Front Psychiatry. 2017 Jun 12;8:79. doi: 10.3389/fpsyt.2017.00079. eCollection 2017.

18.

From Behavioral Facilitation to Inhibition: The Neuronal Correlates of the Orienting and Reorienting of Auditory Attention.

Hanlon FM, Dodd AB, Ling JM, Bustillo JR, Abbott CC, Mayer AR.

Front Hum Neurosci. 2017 Jun 6;11:293. doi: 10.3389/fnhum.2017.00293. eCollection 2017.

19.

Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia.

Lin D, Chen J, Ehrlich S, Bustillo JR, Perrone-Bizzozero N, Walton E, Clark VP, Wang YP, Sui J, Du Y, Ho BC, Schulz CS, Calhoun VD, Liu J.

Schizophr Bull. 2018 Feb 15;44(2):443-452. doi: 10.1093/schbul/sbx068.

20.

By our bootstraps: Comparing methods for measuring auditory 40 Hz steady-state neural activity.

Edgar JC, Fisk CL IV, Chen YH, Stone-Howell B, Hunter MA, Huang M, Bustillo JR, Cañive JM, Miller GA.

Psychophysiology. 2017 Aug;54(8):1110-1127. doi: 10.1111/psyp.12876. Epub 2017 Apr 19.

21.

Socio-neuro risk factors for suicidal behavior in criminal offenders with psychotic disorders.

Harenski CL, Brook M, Kosson DS, Bustillo JR, Harenski KA, Caldwell MF, Van Rybroek GJ, Koenigs M, Decety J, Thornton DM, Calhoun VD, Kiehl KA.

Soc Cogn Affect Neurosci. 2017 Jan 1;12(1):70-80. doi: 10.1093/scan/nsw164.

22.

Multimodal Classification of Schizophrenia Patients with MEG and fMRI Data Using Static and Dynamic Connectivity Measures.

Cetin MS, Houck JM, Rashid B, Agacoglu O, Stephen JM, Sui J, Canive J, Mayer A, Aine C, Bustillo JR, Calhoun VD.

Front Neurosci. 2016 Oct 19;10:466. eCollection 2016.

23.

Magnetoencephalographic and functional MRI connectomics in schizophrenia via intra- and inter-network connectivity.

Houck JM, Çetin MS, Mayer AR, Bustillo JR, Stephen J, Aine C, Cañive J, Perrone-Bizzozero N, Thoma RJ, Brookes MJ, Calhoun VD.

Neuroimage. 2017 Jan 15;145(Pt A):96-106. doi: 10.1016/j.neuroimage.2016.10.011. Epub 2016 Oct 8.

24.

Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.

Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Stromberg S, Canive J, Gasparovic C.

Schizophr Bull. 2017 May 1;43(3):611-619. doi: 10.1093/schbul/sbw122.

25.

Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study.

Buckley PF, Schooler NR, Goff DC, Kopelowicz A, Lauriello J, Manschreck TC, Mendelowitz A, Miller DD, Wilson DR, Ames D, Bustillo JR, Kane JM, Looney SW.

Psychiatr Serv. 2016 Dec 1;67(12):1370-1372. Epub 2016 Aug 1.

PMID:
27476806
26.

Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia.

Wright C, Gupta CN, Chen J, Patel V, Calhoun VD, Ehrlich S, Wang L, Bustillo JR, Perrone-Bizzozero NI, Turner JA.

Transl Psychiatry. 2016 Feb 2;6:e724. doi: 10.1038/tp.2015.211.

27.

Hemodynamic response function abnormalities in schizophrenia during a multisensory detection task.

Hanlon FM, Shaff NA, Dodd AB, Ling JM, Bustillo JR, Abbott CC, Stromberg SF, Abrams S, Lin DS, Mayer AR.

Hum Brain Mapp. 2016 Feb;37(2):745-55. doi: 10.1002/hbm.23063. Epub 2015 Nov 24.

28.

Neuropsychological profile in adult schizophrenia measured with the CMINDS.

van Erp TG, Preda A, Turner JA, Callahan S, Calhoun VD, Bustillo JR, Lim KO, Mueller B, Brown GG, Vaidya JG, McEwen S, Belger A, Voyvodic J, Mathalon DH, Nguyen D, Ford JM, Potkin SG; FBIRN.

Psychiatry Res. 2015 Dec 30;230(3):826-34. doi: 10.1016/j.psychres.2015.10.028. Epub 2015 Oct 26.

29.

An fMRI study of multimodal selective attention in schizophrenia.

Mayer AR, Hanlon FM, Teshiba TM, Klimaj SD, Ling JM, Dodd AB, Calhoun VD, Bustillo JR, Toulouse T.

Br J Psychiatry. 2015 Nov;207(5):420-8. doi: 10.1192/bjp.bp.114.155499. Epub 2015 Sep 17. Erratum in: Br J Psychiatry. 2019 Feb;214(2):118.

30.

MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia.

Patel VS, Kelly S, Wright C, Gupta CN, Arias-Vasquez A, Perrone-Bizzozero N, Ehrlich S, Wang L, Bustillo JR, Morris D, Corvin A, Cannon DM, McDonald C, Donohoe G, Calhoun VD, Turner JA.

Neurosci Lett. 2015 Aug 18;602:44-9. doi: 10.1016/j.neulet.2015.06.039. Epub 2015 Jun 26.

31.

Spatial Variance in Resting fMRI Networks of Schizophrenia Patients: An Independent Vector Analysis.

Gopal S, Miller RL, Michael A, Adali T, Cetin M, Rachakonda S, Bustillo JR, Cahill N, Baum SA, Calhoun VD.

Schizophr Bull. 2016 Jan;42(1):152-60. doi: 10.1093/schbul/sbv085. Epub 2015 Jun 23.

32.

The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study.

Caprihan A, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Canive J, Gasparovic C, Bustillo JR.

Neuropsychopharmacology. 2015 Aug;40(9):2248-57. doi: 10.1038/npp.2015.72. Epub 2015 Mar 18.

33.

Reproducibility of phase rotation stimulated echo acquisition mode at 3T in schizophrenia: Emphasis on glutamine.

Bustillo JR, Rediske N, Jones T, Rowland LM, Abbott C, Wijtenburg SA.

Magn Reson Med. 2016 Feb;75(2):498-502. doi: 10.1002/mrm.25638. Epub 2015 Mar 11.

34.

Multisensory stimuli elicit altered oscillatory brain responses at gamma frequencies in patients with schizophrenia.

Stone DB, Coffman BA, Bustillo JR, Aine CJ, Stephen JM.

Front Hum Neurosci. 2014 Nov 4;8:788. doi: 10.3389/fnhum.2014.00788. eCollection 2014.

35.

Genetic influences on cognitive endophenotypes in schizophrenia.

Yeo RA, Gangestad SW, Walton E, Ehrlich S, Pommy J, Turner JA, Liu J, Mayer AR, Schulz SC, Ho BC, Bustillo JR, Wassink TH, Sponheim SR, Morrow EM, Calhoun VD.

Schizophr Res. 2014 Jun;156(1):71-5. doi: 10.1016/j.schres.2014.03.022. Epub 2014 Apr 24.

36.

Thalamus and posterior temporal lobe show greater inter-network connectivity at rest and across sensory paradigms in schizophrenia.

Çetin MS, Christensen F, Abbott CC, Stephen JM, Mayer AR, Cañive JM, Bustillo JR, Pearlson GD, Calhoun VD.

Neuroimage. 2014 Aug 15;97:117-26. doi: 10.1016/j.neuroimage.2014.04.009. Epub 2014 Apr 13.

37.

A multi-scanner study of subcortical brain volume abnormalities in schizophrenia.

van Erp TG, Greve DN, Rasmussen J, Turner J, Calhoun VD, Young S, Mueller B, Brown GG, McCarthy G, Glover GH, Lim KO, Bustillo JR, Belger A, McEwen S, Voyvodic J, Mathalon DH, Keator D, Preda A, Nguyen D, Ford JM, Potkin SG, Fbirn.

Psychiatry Res. 2014 Apr 30;222(1-2):10-6. doi: 10.1016/j.pscychresns.2014.02.011. Epub 2014 Feb 28.

38.

Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.

Bustillo JR, Chen H, Jones T, Lemke N, Abbott C, Qualls C, Canive J, Gasparovic C.

JAMA Psychiatry. 2014 Mar;71(3):265-72. doi: 10.1001/jamapsychiatry.2013.3939.

PMID:
24402128
39.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.

Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, Almasy L, Almeida J, Alpert K, Andreasen NC, Andreassen OA, Apostolova LG, Appel K, Armstrong NJ, Aribisala B, Bastin ME, Bauer M, Bearden CE, Bergmann O, Binder EB, Blangero J, Bockholt HJ, Bøen E, Bois C, Boomsma DI, Booth T, Bowman IJ, Bralten J, Brouwer RM, Brunner HG, Brohawn DG, Buckner RL, Buitelaar J, Bulayeva K, Bustillo JR, Calhoun VD, Cannon DM, Cantor RM, Carless MA, Caseras X, Cavalleri GL, Chakravarty MM, Chang KD, Ching CR, Christoforou A, Cichon S, Clark VP, Conrod P, Coppola G, Crespo-Facorro B, Curran JE, Czisch M, Deary IJ, de Geus EJ, den Braber A, Delvecchio G, Depondt C, de Haan L, de Zubicaray GI, Dima D, Dimitrova R, Djurovic S, Dong H, Donohoe G, Duggirala R, Dyer TD, Ehrlich S, Ekman CJ, Elvsåshagen T, Emsell L, Erk S, Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher SE, Foroud T, Fox PT, Francks C, Frangou S, Frey EM, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn DC, Godlewska B, Goldstein RZ, Gollub RL, Grabe HJ, Grimm O, Gruber O, Guadalupe T, Gur RE, Gur RC, Göring HH, Hagenaars S, Hajek T, Hall GB, Hall J, Hardy J, Hartman CA, Hass J, Hatton SN, Haukvik UK, Hegenscheid K, Heinz A, Hickie IB, Ho BC, Hoehn D, Hoekstra PJ, Hollinshead M, Holmes AJ, Homuth G, Hoogman M, Hong LE, Hosten N, Hottenga JJ, Hulshoff Pol HE, Hwang KS, Jack CR Jr, Jenkinson M, Johnston C, Jönsson EG, Kahn RS, Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok JB, Lagopoulos J, Laje G, Landen M, Landman BA, Lauriello J, Lawrie SM, Lee PH, Le Hellard S, Lemaître H, Leonardo CD, Li CS, Liberg B, Liewald DC, Liu X, Lopez LM, Loth E, Lourdusamy A, Luciano M, Macciardi F, Machielsen MW, Macqueen GM, Malt UF, Mandl R, Manoach DS, Martinot JL, Matarin M, Mather KA, Mattheisen M, Mattingsdal M, Meyer-Lindenberg A, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery GW, Morris DW, Moses EK, Mueller BA, Muñoz Maniega S, Mühleisen TW, Müller-Myhsok B, Mwangi B, Nauck M, Nho K, Nichols TE, Nilsson LG, Nugent AC, Nyberg L, Olvera RL, Oosterlaan J, Ophoff RA, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z, Pearlson GD, Penninx BW, Peterson CP, Pfennig A, Phillips M, Pike GB, Poline JB, Potkin SG, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher SL, Roffman JL, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose EJ, Royle NA, Rujescu D, Ryten M, Sachdev PS, Salami A, Satterthwaite TD, Savitz J, Saykin AJ, Scanlon C, Schmaal L, Schnack HG, Schork AJ, Schulz SC, Schür R, Seidman L, Shen L, Shoemaker JM, Simmons A, Sisodiya SM, Smith C, Smoller JW, Soares JC, Sponheim SR, Sprooten E, Starr JM, Steen VM, Strakowski S, Strike L, Sussmann J, Sämann PG, Teumer A, Toga AW, Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee NJ, van Eijk K, van Erp TG, van Haren NE, van 't Ent D, van Tol MJ, Valdés Hernández MC, Veltman DJ, Versace A, Völzke H, Walker R, Walter H, Wang L, Wardlaw JM, Weale ME, Weiner MW, Wen W, Westlye LT, Whalley HC, Whelan CD, White T, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Zilles D, Zwiers MP, Thalamuthu A, Schofield PR, Freimer NB, Lawrence NS, Drevets W; Alzheimer’s Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group.

Brain Imaging Behav. 2014 Jun;8(2):153-82. doi: 10.1007/s11682-013-9269-5. Review.

40.
41.

Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation.

van Erp TG, Guella I, Vawter MP, Turner J, Brown GG, McCarthy G, Greve DN, Glover GH, Calhoun VD, Lim KO, Bustillo JR, Belger A, Ford JM, Mathalon DH, Diaz M, Preda A, Nguyen D, Macciardi F, Potkin SG.

Biol Psychiatry. 2014 Mar 1;75(5):398-405. doi: 10.1016/j.biopsych.2013.06.016. Epub 2013 Aug 1.

42.

Clozapine-induced obsessive-compulsive symptoms in bipolar disorder.

Lemke NT, Bustillo JR.

Am J Psychiatry. 2013 Aug;170(8):930. doi: 10.1176/appi.ajp.2013.13010144. No abstract available.

PMID:
23903341
43.

The impact of parent socio-economic status on executive functioning and cortical morphology in individuals with schizophrenia and healthy controls.

Yeo RA, Martinez D, Pommy J, Ehrlich S, Schulz SC, Ho BC, Bustillo JR, Calhoun VD.

Psychol Med. 2014 Apr;44(6):1257-65. doi: 10.1017/S0033291713001608. Epub 2013 Jul 19.

44.

Using joint ICA to link function and structure using MEG and DTI in schizophrenia.

Stephen JM, Coffman BA, Jung RE, Bustillo JR, Aine CJ, Calhoun VD.

Neuroimage. 2013 Dec;83:418-30. doi: 10.1016/j.neuroimage.2013.06.038. Epub 2013 Jun 15.

45.

High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.

Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA.

J Clin Psychopharmacol. 2013 Aug;33(4):485-90. doi: 10.1097/JCP.0b013e3182977308.

PMID:
23775057
46.

The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia.

Gollub RL, Shoemaker JM, King MD, White T, Ehrlich S, Sponheim SR, Clark VP, Turner JA, Mueller BA, Magnotta V, O'Leary D, Ho BC, Brauns S, Manoach DS, Seidman L, Bustillo JR, Lauriello J, Bockholt J, Lim KO, Rosen BR, Schulz SC, Calhoun VD, Andreasen NC.

Neuroinformatics. 2013 Jul;11(3):367-88. doi: 10.1007/s12021-013-9184-3.

47.

Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference.

Chen J, Calhoun VD, Pearlson GD, Perrone-Bizzozero N, Sui J, Turner JA, Bustillo JR, Ehrlich S, Sponheim SR, Cañive JM, Ho BC, Liu J.

Neuroimage. 2013 Dec;83:384-96. doi: 10.1016/j.neuroimage.2013.05.073. Epub 2013 May 28.

48.

The impact of copy number deletions on general cognitive ability and ventricle size in patients with schizophrenia and healthy control subjects.

Yeo RA, Gangestad SW, Liu J, Ehrlich S, Thoma RJ, Pommy J, Mayer AR, Schulz SC, Wassink TH, Morrow EM, Bustillo JR, Sponheim SR, Ho BC, Calhoun VD.

Biol Psychiatry. 2013 Mar 15;73(6):540-5. doi: 10.1016/j.biopsych.2012.10.013. Epub 2012 Dec 11.

49.

Frontotemporal anatomical connectivity and working-relational memory performance predict everyday functioning in schizophrenia.

Hanlon FM, Houck JM, Klimaj SD, Caprihan A, Mayer AR, Weisend MP, Bustillo JR, Hamilton DA, Tesche CD.

Psychophysiology. 2012 Oct;49(10):1340-52. doi: 10.1111/j.1469-8986.2012.01448.x. Epub 2012 Aug 6.

50.

Cigarette smoking and white matter microstructure in schizophrenia.

Cullen KR, Wallace S, Magnotta VA, Bockholt J, Ehrlich S, Gollub RL, Manoach DS, Ho BC, Clark VP, Lauriello J, Bustillo JR, Schulz SC, Andreasen NC, Calhoun VD, Lim KO, White T.

Psychiatry Res. 2012 Feb 28;201(2):152-8. doi: 10.1016/j.pscychresns.2011.08.010. Epub 2012 Mar 3.

Supplemental Content

Loading ...
Support Center